Nikhil Tandon and colleagues explore the impact of a quality improvement strategy for patients with type 2 diabetes 6.5 years after its implementation for the CARRS randomised trial.
As the market for anti-obesity drugs in India grows rapidly, pharma majors like Dr. Reddy's, Zydus, and Sun Pharma are competing to quickly enter the market with weight-loss drugs - Issue Date: Jan 07, 2024
The top 5 Best Places to Work in India for 2023 revealed, Novo Nordisk GBS ranks no. 1 sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
Sun Pharma, Dr. Reddy's, Lupin, Torrent, and Zydus Cadila progressing obesity drug candidates in response to rising demand. Notable developments include Sun Pharma's Phase 1 studies and Dr. Reddy’s Laboratories' permission for a semaglutide bioequivalence study
Indian pharma cos speed up anti-obesity drug development amidst high demand and Ozempic sales surge businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.